Navigation Links
China Medical Technologies Reports Second Fiscal Quarter Financial Results
Date:11/17/2010

>

41,399Convertible notes

2,777,086

2,556,014

2,528,848

377,976Deferred income taxes

67,134

72,518

78,408

11,720Total liabilities

3,105,373

2,895,222

2,884,241

431,095Shareholders' equityOrdinary shares US$0.1 par value:

500,000,000 authorized; 322,680,001 issued and outstanding as of March 31, 2010, June 30, 2010 and September 30, 2010

258,840

258,840

258,840

38,688Additional paid-in capital

808,221

820,778

830,016

124,058Treasury stock

(45,143)

(47,108)

(47,108)

(7,041)Accumulated other comprehensive loss

(70,556)

(70,731)

(74,412)

(11,122)Retained earnings

852,334

886,012

883,076

131,990Total shareholders' equity

1,803,696

1,847,791

1,850,412

276,573Total liabilities and shareholders' equity

4,909,069

4,743,013

4,734,653

707,668China Medical Technologies, Inc.Unaudited Condensed Consolidated Statements of IncomeFor the Three Months EndedSeptember 30, 2009June 30, 2010September 30, 2010RMBRMBRMBUS$   As adjusted (4)(in thousands except for per ADS information)Revenues, net (1)

166,066

186,170

201,834

30,167Cost of revenues (2)

(57,517)

(61,354)

(90,477)

(13,523)Gross profit

108,549

124,816

111,357

16,644Operating expensesResearch and development (2)

(9,500)

(10,632)

(10,877)

(1,625)Sales and marketing (2)

(17,432)

(18,266)

(21,473)

(3,209)General and administrative (2)

(45,130)

(25,149)

(25,048)

(3,744) Amortization of SPR intangible assets

(27,357)

(27,329)

-

-Total operating expenses

(99,419)

(81,376)


'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 The Temple Health & ... to a 5,000-square-foot building at 1802 South First St. in ... designated by the City of Temple ... White and the Central Texas Veterans Health Care System, the ... space to early stage biotechnology and life science companies. ...
(Date:3/27/2015)... XRpro Sciences, Inc., a provider of ... services which features high throughput transporter and ion ... results for the year ended December 31, 2014. ... XRpro Sciences commented, "We have completed a number ... to commercial stage in large part by achieving ...
(Date:3/27/2015)... BROOKFIELD, Wis. , March 27, 2015 /PRNewswire/ ... 40,000 unit shipments of incontinence devices for women. ... terrific, but the most gratifying part is the ... receive from women whose lives have been positively ... , president of InControl. InControl recently ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2
... RONKONKOMA, N.Y., March 14, 2011 NBTY, Inc. (Nasdaq: ... manufacturer and marketer of nutritional supplements in the United ... a conference call to review its fiscal first quarter ... 2011 at 10:00 AM (ET).  These results are posted ...
... health division of Eli Lilly and Company (NYSE: ... an irrevocable, unconditional offer to acquire the animal health ... Company. The two companies have notified the appropriate European ... Janssen,s animal health business is primarily European-focused, targeting disease ...
Cached Medicine Technology:NBTY to Webcast Fiscal First Quarter Conference Call 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 3
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... March 28, 2015 One in three ... to research presented today at the American Orthopaedic Society ... study examined the long term success of surgery for ... examined survey data from 242 patients who underwent ACL ... P. Roe, MBBS, FRACS, from North Sydney Orthopaedic and ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the ... the first time, key information for understanding and treating ... newly posted story on the Surviving Mesothelioma website. ... Columbia, the British Columbia Cancer Agency, and PhenoPath lab ... molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
(Date:3/28/2015)... 2015 Purity Products®, a leading ... the release of their revolutionary new weight loss ... randomized, double-blind, placebo-controlled clinical studies to be effective ... size. MuffinStop™ is a combination of two traditionally ... fused together to create one of the most ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... ... disabled car and killed the driver. , ... New York, NY (PRWEB) February 9, 2010 -- A truck driver killed a mother of two ... His truck crashed into her disabled car on the New York State Thruway. The accident happened ...
... anxiety and depression are most likely to use a shade ... the open access journal BMC Medical Research Methodology ... Wheel, which can be used to study people,s preferred pigment ... Professor of Medicine and Gastroenterology at University Hospital South Manchester, ...
... the two drugs together, researchers say , , MONDAY, ... who take both tamoxifen and the antidepressant Paxil may ... effectiveness, Canadian researchers report. , "Paxil can deprive women ... used in combination with tamoxifen for a long time," ...
... CLEARWATER, Fla. , Feb. 8 Lincare Holdings Inc. (Nasdaq: ... year ended December 31, 2009 . , For the quarter ended ... compared with net revenues of $415.1 million for the fourth ... revenues in the fourth quarter of 2009 was comprised of 13% internal ...
... by Pier Paolo Pandolfi, at Beth Israel Deaconess Medical ... senescence (i.e., irreversible arrest of cell growth) and determined ... development and growth in mice. Previous work by ... Pten leads to a senescence response that opposes tumorigenesis. ...
... predict the progression to dementia in older adults with ... decisions) but not in those with memory dysfunction, according ... Archives of Neurology, one of the JAMA/Archives journals. ... risk factor for the development of dementia in late ...
Cached Medicine News:Health News:New York Truck Driver Watching Porn Kills Mother, Appalls Personal Injury Lawyers Such As David Perecman 2Health News:New York Truck Driver Watching Porn Kills Mother, Appalls Personal Injury Lawyers Such As David Perecman 3Health News:Depressed people feel more gray than blue 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 7Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 8Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 9Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 10Health News:Hypertension may predict dementia in older adults with certain cognitive deficits 2
The ImmunoWELL Borrelia M Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi,IgM antibodies in serum and is used as an aid in the diag...
... Mono-G Test is a qualitative enzyme ... to Epstein-Barr virus capsid antigen (EBV-VCA), ... (CMV), and Toxoplasma. When used in ... an aid in the serodiagnosis of ...
... ImmunoWELL VCA IgM Test is an ELISA method ... Epstein-Barr Virus viral capsid antigen (VCA) in human ... in conjunction with other testing such as the ... early antigen tests and/or heterophile tests, the results ...
... Borrelia DotBlot M Tests are qualitative enzyme ... Borrelia burgdorferi antibodies (IgG or IgM, respectively) ... these tests should be supplemented with a ... can be used to support a clinical ...
Medicine Products: